Patient info Open main menu

Edoxaban 30 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
30 mg
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Edoxaban 30 mg film-coated tablets

1. What Edoxaban Tablet is and what it is used for

Edoxaban Tablet contains the active substance edoxaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent blood clots from forming. It works by blocking the activity of factor Xa, which is an important component of blood clotting.

Edoxaban Tablet is used in adults to:

  • prevent blood clots in the brain (stroke) and other blood vessels in the body if you have a form of irregular heart rhythm called nonvalvular atrial fibrillation and at least one additional risk factor, such as heart failure, previous stroke or high blood pressure;
  • treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels in the lungs (pulmonary embolism), and to prevent blood clots from re-occurring in the blood vessels in the legs and/or lungs.

2. What you need to know before you take Edoxaban Tablet

Do not take Edoxaban Tablet

  • if you are allergic to edoxaban or any of the other ingredients of this medicine (listed in section 6);
  • if you are actively bleeding;
  • if you have a disease or condition that increases the risk of serious bleeding (e.g. stomach ulcer, injury or bleeding in the brain, or recent surgery of the brain or eyes);
  • if you are taking other medicines to prevent blood clotting (e.g. warfarin, dabigatran, rivaroxaban, apixaban or heparin), except when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open;
  • if you have a liver disease which leads to an increased risk of bleeding;
  • if you have uncontrolled high blood pressure;
  • if you are pregnant or breast feeding.

Warnings and precautions

Talk to your doctor or pharmacist before taking Edoxaban Tablet

  • if you have an increased risk of bleeding, as could be the case if you have any of the following conditions:

    • end stage kidney disease or if you are on dialysis;
    • severe liver disease;
    • bleeding disorders;
    • a problem with the blood vessels in the back of your eyes (retinopathy);
    • recent bleeding in your brain (intracranial or intracerebral bleeding);
    • problems with the blood vessels in your brain or spinal column;
    • if you have a mechanical heart valve.

Edoxaban 15 mg dose is to be used when changing from Edoxaban 30 mg Tablet to a vitamin K antagonist (e.g. warfarin) (see section 3. How to take Edoxaban Tablet). If an alternative dose is required, other edoxaban products offering such an option should be used.

Take special care with Edoxaban Tablet,

  • if you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk for blood clots), tell your doctor who will decide if the treatment may need to be changed.

If you need to have an operation,

  • it is very important to take Edoxaban Tablet before and after the operation exactly at the times you have been told by your doctor. If possible, Edoxaban Tablet should be stopped at least 24 hours before an operation. Your doctor will determine when to restart Edoxaban Tablet.

    In emergency situations your physician will help determine the appropriate actions regarding Edoxaban Tablet.

Children and adolescents

Edoxaban Tablet is not recommended in children and adolescents under 18 years of age.

Other medicines and Edoxaban Tablet

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

If you are taking any of the following:

  • some medicines for fungal infections (e.g. ketoconazole);
  • medicines to treat abnormal heart beat (e.g. dronedarone, quinidine, verapamil);
  • other medicines to reduce blood clotting (e.g. heparin, clopidogrel or vitamin K antagonists such as warfarin, acenocoumarol, phenprocoumon or dabigatran, rivaroxaban, apixaban);
  • antibiotic medicines (e.g. erythromycin, clarithromycin);
  • medicines to prevent organ rejection after transplantation (e.g. ciclosporin);
  • anti-inflammatory and pain-relieving medicines (e.g. naproxen or acetylsalicylic acid);
  • antidepressant medicines called selective serotonin reuptake inhibitors or serotonin- norepinephrine reuptake inhibitors;

If any of the above apply to you, tell your doctor before taking Edoxaban Tablet, because these medicines may increase the effects of Edoxaban Tablet and the chance of unwanted bleeding. Your doctor will decide, if you should be treated with Edoxaban Tablet and if you should be kept under observation.

If you are taking any of the following:

  • some medicines for treatment of epilepsy (e.g. phenytoin, carbamazepine, phenobarbital);
  • St John’s Wort, a herbal product used for anxiety and mild depression;
  • rifampicin, an antibiotic medicine.

If any of the above apply to you, tell your doctor before taking Edoxaban Tablet, because the effect of Edoxaban Tablet may be reduced. Your doctor will decide if you should be treated with Edoxaban Tablet and if you should be kept under observation.

Pregnancy and breast-feeding

Do not take Edoxaban Tablet if you are pregnant or breast-feeding. If there is a chance that you could become pregnant, use a reliable contraceptive while you are taking Edoxaban Tablet. If you become pregnant while you are taking Edoxaban Tablet, immediately tell your doctor, who will decide how you should be treated.

Driving and using machines

Edoxaban Tablet has no or negligible effects on your ability to drive or use machines.

Edoxaban Tablet contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially ‘sodium-free’.

3. How to take Edoxaban Tablet

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

How much to take

The recommended dose is one 60 mg tablet once daily.

  • If you have impaired kidney function, the dose may be reduced to one 30 mg tablet once daily by your doctor;
  • if your body weight is 60 kg or lower, the recommended dose is one 30 mg tablet once daily;
  • if your doctor has prescribed medicines known as P-gp inhibitors: ciclosporin, dronedarone, erythromycin, or ketoconazole, the recommended dose is one 30 mg tablet once daily.

How to take the tablet

Swallow the tablet, preferably with water.

Edoxaban Tablet can be taken with or without food.

If you have difficulty swallowing the tablet whole, talk to your doctor about other ways to take Edoxaban Tablet. The tablet may be crushed and mixed with water or apple puree immediately before you take it.

If necessary, your doctor may also give you the crushed Edoxaban Tablet through a tube via the nose (nasogastric tube) or a tube in the stomach (gastric feeding tube).

Your doctor may change your anticoagulant treatment as follows:

Changing from vitamin K antagonists (e.g. warfarin) to Edoxaban Tablet

Stop taking the vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to start taking Edoxaban Tablet.

Changing from non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban) to Edoxaban Tablet Stop taking the previous medicines (e.g. dabigatran, rivaroxaban, or apixaban) and start Edoxaban Tablet at the time of the next scheduled dose.

Changing from parenteral anticoagulants (e.g. heparin) to Edoxaban Tablet

Stop taking the anticoagulant (e.g. heparin) and start Edoxaban Tablet at the time of the next scheduled anticoagulant dose.

Changing from Edoxaban Tablet to vitamin K antagonists (e.g. warfarin)

If you currently take 60 mg Edoxaban Tablet:

Your doctor will tell you to reduce your dose of Edoxaban Tablet to a 30 mg tablet once daily and to take it together with a vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to stop taking Edoxaban Tablet.

If you currently take 30 mg (dose reduced) Edoxaban Tablet:

Your doctor will tell you to reduce your dose of edoxaban to a 15 mg once daily (if an alternative dose is required, other edoxaban products offering such an option should be used) and to take it together with a vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to stop taking Edoxaban Tablet.

Changing from Edoxaban Tablet to non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban) Stop taking Edoxaban Tablet and start the non-VKA anticoagulant (e.g. dabigatran, rivaroxaban, or apixaban) at the time of the next scheduled dose of Edoxaban Tablet.

Changing from Edoxaban Tablet to parenteral anticoagulants (e.g. heparin)

Stop taking Edoxaban Tablet and start the parenteral anticoagulant (e.g. heparin) at the time of the next scheduled dose of Edoxaban Tablet.

Patients undergoing cardioversion:

If your abnormal heartbeat needs to be restored to normal by a procedure called cardioversion, take Edoxaban Tablet at the times your doctor tells you to prevent blood clots in the brain and other blood vessels in your body.

If you take more Edoxaban Tablet than you should

Tell your doctor immediately if you have taken too many Edoxaban Tablets.

If you take more Edoxaban Tablet than recommended, you may have an increased risk of bleeding.

If you forget to take Edoxaban Tablet

You should take the tablet immediately and then continue the following day with the once daily tablet as usual. Do not take a double dose on the same day to make up for a forgotten dose.

If you stop taking Edoxaban Tablet

Do not stop taking Edoxaban Tablet without talking to your doctor first, because Edoxaban Tablet treats and prevents serious conditions.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Like other similar medicines (medicines to reduce blood clotting), Edoxaban Tablet may cause bleeding which may potentially be life-threatening. In some cases the bleeding may not be obvious.

If you experience any bleeding event that does not stop by itself or if you experience signs of excessive bleeding (exceptional weakness, tiredness, paleness, dizziness, headache or unexplained swelling) consult your doctor immediately.

Your doctor may decide to keep you under closer observation or change your medicine.

Overall list of possible side effects:

Common (may affect up to 1 in 10 people)

  • stomach ache;
  • abnormal liver blood tests;
  • bleeding from the skin or under the skin;
  • anaemia (low levels of red blood cells);
  • bleeding from the nose;
  • bleeding from the vagina;
  • rash;
  • bleeding in the bowel;
  • bleeding from the mouth and/or throat;
  • blood found in your urine;
  • bleeding following an injury (puncture);
  • bleeding in the stomach;
  • dizziness;
  • feeling sick;
  • headache;
  • itching.

Uncommon (may affect up to 1 in 100 people)

  • bleeding in the eyes;
  • bleeding from a surgical wound following an operation;
  • blood in the spit when coughing;
  • bleeding in the brain;
  • other types of bleeding;
  • reduced number of platelets in your blood (which can affect clotting);
  • allergic reaction;
  • hives.

Rare (may affect up to 1 in 1,000 people)

  • bleeding in the muscles;
  • bleeding in joints;
  • bleeding in the abdomen;
  • bleeding in the heart;
  • bleeding inside the skull;
  • bleeding following a surgical procedure;
  • allergic shock;
  • swelling of any part of the body due to allergic reaction.

Not known (frequency cannot be estimated from the available data)

  • bleeding in the kidney sometimes with presence of blood in urine leading to inability of the kidneys to work properly (anticoagulant-related nephropathy).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Edoxaban Tablet

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on each blister or bottle after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Edoxaban Tablet contains

  • The active substance is edoxaban (as tosylate).

    • Edoxaban 30 mg film-coated tablets: Each tablet contains edoxaban tosylate equivalent to 30 mg edoxaban.
    • Edoxaban 60 mg film-coated tablets: Each tablet contains edoxaban tosylate equivalent to 60 mg edoxaban.
  • The other ingredients are:

    • Edoxaban 30 mg film-coated tablets

      Tablet core: Mannitol (E421), hydroxypropylcellulose, crospovidone, silica, colloidal anhydrous, magnesium stearate Tablet coat: Macrogol poly(vinyl alcohol) grafted copolymer (E1209), titanium dioxide (E171), kaolin, heavy, copovidone , sodium laurilsulfate (see section 2), iron oxide red (E172) (tablet coating).

    • Edoxaban 60 mg film-coated tablets

      Tablet core: Mannitol (E421), hydroxypropylcellulose, crospovidone, silica, colloidal anhydrous, magnesium stearate Table coat: Macrogol poly(vinyl alcohol) grafted copolymer (E1209), titanium dioxide (E171), kaolin, heavy, copovidone , sodium laurilsulfate (see section 2), iron oxide yellow (E172) (tablet coating).

What Edoxaban Tablet looks like and contents of the pack

Edoxaban 30 mg film-coated tablets are pink colour, round biconvex coated tablets (approximately 8 mm), debossed with “7X” on one side and “I” on the other side.

Edoxaban 60 mg film-coated tablets are yellow colour, round biconvex coated tablets (approximately 10 mm), debossed with “7X” on one side and “H” on the other side.

They come in blisters in cartons of 10, 14, 28, 30, 56, 60, 84, 90 or 98 film-coated tablets or unit dose blisters in cartons of 10 x 1 or 50 x 1 film-coated tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Cipla (EU) Limited,

Dixcart House, Addlestone Road,

Bourne Business Park, Addlestone,

Surrey KT15 2LE

United Kingdom

Manufacturer

Synthon Hispania, S.L.

Calle De Castello 1

Sant Boi De Llobregat

Barcelona

08830

Spain

Synthon B.V.

Microweg 22

Nijmegen

Gelderland

6545 CM

Netherlands

Synthon s.r.o.

Brnenska 597/32

Blansko

Jihomoravsky

678 01

Czechia

This leaflet was last revised in 03/2026.

XXXXXXXX

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 36390/0475

Last revision stated in the text: March 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Edoxaban 30 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Edoxaban
Strength 30 mg
Pharmaceutical form Oral tablet
Pink, round-shaped film-coated tablets debossed with “30” on one side and plain on the other side, with a diameter of 8.4 mm ± 5%.
How is it taken Oral
Excipients Mannitol (E421), Hydroxypropylcellulose (E463), Crospovidone (E1202), Starch, Pregelatinized (Maize), Silica, Colloidal Anhydrous (E551) Magnesium stearate (E470b), Carmellose sodium (E466), Maltodextrin, Glucose monohydrate, Lecithin (Soya) (E322), Calcium carbonate (E170), Iron Oxide Red (E172)
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Antithrombotic agents, direct factor Xa inhibitors
  1. B Blood and blood forming organ drugs
    1. B01 Antithrombotic agents
      1. B01A Antithrombotic agents
        1. B01AF Direct factor Xa inhibitors
          1. B01AF03 edoxaban
Marketing authorisation PL 04569/1905 (first authorised 3 June 2026), PL 36390/0475
Marketing authorisation holder Generics [UK] Limited t/a Viatris
Codes BNF 02080200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.